TrialClinical cancer research : an official journal of the American Association for Cancer Research2024

SWOG/NCI Phase II Dual Anti-CTLA-4/PD-1 Blockade in Rare Tumors: Nonepithelial Ovarian Cancer.

Young Kwang Chae et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.